DARE
Price
$2.47
Change
+$0.38 (+18.18%)
Updated
Dec 12 closing price
Capitalization
35.29M
Intraday BUY SELL Signals
RIGL
Price
$40.78
Change
-$1.27 (-3.02%)
Updated
Dec 12 closing price
Capitalization
740.21M
Intraday BUY SELL Signals
Interact to see
Advertisement

DARE vs RIGL

Header iconDARE vs RIGL Comparison
Open Charts DARE vs RIGLBanner chart's image
Dare Bioscience
Price$2.47
Change+$0.38 (+18.18%)
Volume$2.19M
Capitalization35.29M
Rigel Pharmaceuticals
Price$40.78
Change-$1.27 (-3.02%)
Volume$563.93K
Capitalization740.21M
DARE vs RIGL Comparison Chart in %
DARE
Daily Signal:
Gain/Loss:
RIGL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Nektar Therapeutics (NASDAQ:NKTR), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.21B. The market cap for tickers in the group ranges from 58 to 114.69B. VRTX holds the highest valuation in this group at 114.69B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 65%. NBY experienced the highest price growth at 158%, while BPTSY experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was -7% and the average quarterly volume growth was 72%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 80
Price Growth Rating: 54
SMR Rating: 92
Profit Risk Rating: 93
Seasonality Score: 17 (-100 ... +100)

Market Cap

The average market capitalization across the group is 396.56M. The market cap for tickers in the group ranges from 29.86M to 763.26M. RIGL holds the highest valuation in this group at 763.26M. The lowest valued company is DARE at 29.86M.

High and low price notable news

The average weekly price growth across all stocks in the group was 3%. For the same group, the average monthly price growth was 9%, and the average quarterly price growth was 37%. DARE experienced the highest price growth at 17%, while RIGL experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the group was 121%. For the same stocks of the group, the average monthly volume growth was 194% and the average quarterly volume growth was 3,336%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 65
P/E Growth Rating: 88
Price Growth Rating: 50
SMR Rating: 54
Profit Risk Rating: 87
Seasonality Score: 47 (-100 ... +100)
VS
DARE vs. RIGL commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DARE is a Buy and RIGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (DARE: $2.09 vs. RIGL: $42.05)
Brand notoriety: DARE and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DARE: 281% vs. RIGL: 65%
Market capitalization -- DARE: $35.29M vs. RIGL: $740.21M
DARE [@Biotechnology] is valued at $35.29M. RIGL’s [@Biotechnology] market capitalization is $740.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DARE’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 1 green FA rating(s).

  • DARE’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 1 green, 4 red.
According to our system of comparison, RIGL is a better buy in the long-term than DARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DARE’s TA Score shows that 4 TA indicator(s) are bullish while RIGL’s TA Score has 5 bullish TA indicator(s).

  • DARE’s TA Score: 4 bullish, 5 bearish.
  • RIGL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than DARE.

Price Growth

DARE (@Biotechnology) experienced а +16.76% price change this week, while RIGL (@Biotechnology) price change was -11.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RIGL($740M) has a higher market cap than DARE($35.3M). RIGL has higher P/E ratio than DARE: RIGL (6.59) vs DARE (0.10). RIGL YTD gains are higher at: 150.000 vs. DARE (-33.013). RIGL has higher annual earnings (EBITDA): 124M vs. DARE (-16.36M). RIGL has more cash in the bank: 137M vs. DARE (23.1M). DARE has less debt than RIGL: DARE (2.93M) vs RIGL (60.9M). RIGL has higher revenues than DARE: RIGL (282M) vs DARE (-57.13K).
DARERIGLDARE / RIGL
Capitalization35.3M740M5%
EBITDA-16.36M124M-13%
Gain YTD-33.013150.000-22%
P/E Ratio0.106.592%
Revenue-57.13K282M-0%
Total Cash23.1M137M17%
Total Debt2.93M60.9M5%
FUNDAMENTALS RATINGS
DARE vs RIGL: Fundamental Ratings
DARE
RIGL
OUTLOOK RATING
1..100
2521
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
10075
SMR RATING
1..100
1009
PRICE GROWTH RATING
1..100
6337
P/E GROWTH RATING
1..100
76100
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RIGL's Valuation (57) in the Biotechnology industry is in the same range as DARE (74). This means that RIGL’s stock grew similarly to DARE’s over the last 12 months.

RIGL's Profit vs Risk Rating (75) in the Biotechnology industry is in the same range as DARE (100). This means that RIGL’s stock grew similarly to DARE’s over the last 12 months.

RIGL's SMR Rating (9) in the Biotechnology industry is significantly better than the same rating for DARE (100). This means that RIGL’s stock grew significantly faster than DARE’s over the last 12 months.

RIGL's Price Growth Rating (37) in the Biotechnology industry is in the same range as DARE (63). This means that RIGL’s stock grew similarly to DARE’s over the last 12 months.

DARE's P/E Growth Rating (76) in the Biotechnology industry is in the same range as RIGL (100). This means that DARE’s stock grew similarly to RIGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DARERIGL
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
76%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 24 days ago
80%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
DARE
Daily Signal:
Gain/Loss:
RIGL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTN154.8113.20
+9.32%
Vail Resorts
GWRS8.670.23
+2.73%
Global Water Resources
EVLV6.840.07
+1.03%
Evolv Technologies Holdings
AMT181.711.45
+0.80%
American Tower Corp
INTZ1.44-0.03
-2.04%
Intrusion

DARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, DARE has been closely correlated with AZTR. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if DARE jumps, then AZTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DARE
1D Price
Change %
DARE100%
+5.03%
AZTR - DARE
73%
Closely correlated
-4.70%
CYTK - DARE
42%
Loosely correlated
+0.75%
AXON - DARE
39%
Loosely correlated
+2.22%
AMRN - DARE
34%
Loosely correlated
+1.61%
SNTI - DARE
32%
Poorly correlated
-5.03%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with SNDX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then SNDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
+2.01%
SNDX - RIGL
35%
Loosely correlated
-1.02%
FTRE - RIGL
34%
Loosely correlated
+2.71%
AKBA - RIGL
33%
Loosely correlated
+1.84%
AGIO - RIGL
33%
Poorly correlated
-1.93%
DNLI - RIGL
32%
Poorly correlated
-1.14%
More